Synergistic Melanoma Treatment System
Legal Citation
Summary of the Inventive Concept
A novel system integrating dapansutrile administration with AI-powered tumor monitoring, IoT-enabled data transmission, blockchain-based data storage, and nanomaterial-based delivery to provide personalized and effective melanoma treatment.
Background and Problem Solved
The original patent disclosed methods for treating melanoma using dapansutrile. However, these methods had limitations in terms of personalized treatment planning, real-time monitoring, and secure data storage. The new inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The system comprises a dapansutrile administration module, an AI-powered tumor monitoring module, and a blockchain-based data storage module. The AI-powered tumor monitoring module analyzes tumor size and response to dapansutrile treatment and provides personalized treatment recommendations. The system can also include a wearable device with a dapansutrile sensor, an IoT-enabled data transmission module, and a user interface. Additionally, a blockchain-based platform can be used to track melanoma treatment outcomes, and a nanomaterial-based delivery system can be employed to target dapansutrile delivery to the tumor site.
Novelty and Inventive Step
The new claims introduce the synergistic combination of dapansutrile administration with AI, IoT, blockchain, and nanomaterial-based technologies, which is not obvious from the original patent. The integration of these distinct technologies provides a novel and non-obvious solution for personalized melanoma treatment.
Alternative Embodiments and Variations
Alternative embodiments of the system could include using different AI algorithms, incorporating additional sensors in the wearable device, or employing different nanomaterials for targeted delivery. Variations could also include using the system for treating other types of cancer or integrating with other medical devices.
Potential Commercial Applications and Market
The Synergistic Melanoma Treatment System has significant commercial potential in the oncology market, particularly in the areas of personalized medicine and cancer treatment. The system's ability to provide real-time monitoring and personalized treatment recommendations could lead to improved treatment outcomes and increased patient satisfaction.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Oncology, medical technology, pharmaceutical treatment methods, and digital health systems with a focus on personalized cancer treatment and monitoring technologies
Person of Ordinary Skill (PHOSITA) Profile
A medical professional with advanced training in oncology, having expertise in pharmaceutical interventions, digital health technologies, data analytics, and personalized medicine approaches, with knowledge of emerging technologies in cancer treatment monitoring and drug delivery
Obviousness Rationale
A person having ordinary skill in the art would recognize that integrating digital monitoring technologies with established pharmaceutical treatments represents a predictable evolution of personalized medicine. The source patent's foundational method of melanoma treatment using dapansutrile provides a clear technological basis for exploring enhanced monitoring and delivery approaches. The PTD's proposed technological integrations represent logical extensions of existing medical technology trends toward precision medicine and data-driven treatment optimization.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,529 |
|---|---|
| Title | Methods for treating melanoma |
| Assignee(s) | OLATEC THERAPEUTICS, INC. |